;The secosteroid hormone 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) plays a
vital role in calcium metabolism, tissue differentiation, and normal bone
growth. Biosynthesis of 1,25(OH)(2)D-3 is catalyzed by the mitochondrial cy
tochrome P450 enzyme 25-hydroxyvitamin D-3 1 alpha-hydroxylase (1 alpha-hyd
roxylase). Although activity of this enzyme has been described in several t
issues. the kidneys are recognized to be the principal site of 1,25(OH)(2)D
-3 production. To date, enzyme activity studies using vitamin D-deficient a
nimals have suggested that 1 alpha-hydroxylase is expressed exclusively in
proximal convoluted tubules. With the recent cloning of 1 alpha-hydroxylase
, specific cRNA probes and in-house polyclonal antiserum have been used to
determine the distribution of 1 alpha-hydroxylase along the human nephron.
Immunohistochemistry and in situ hybridization studies indicated strong exp
ression of 1 alpha-hydroxylase protein and mRNA in the distal convoluted tu
bule, the cortical and medullary part of the collecting ducts, and the papi
llary epithelia. Lower expression was observed along the thick ascending li
mb of the loop of Henle and Bowman's capsule. Weaker and more variable expr
ession of 1 alpha-hydroxylase protein and mRNA was seen in proximal convolu
ted tubules, and no expression was observed in glomeruli or vascular struct
ures. These data show for the first time the distribution of 1 alpha-hydrox
ylase expression in normal human kidney. In contrast to earlier enzyme acti
vity studies conducted in vitamin D-deficient animals, our data indicate th
at the distal nephron is the predominant site of 1 alpha-hydroxylase expres
sion under conditions of vitamin D sufficiency.